Literature DB >> 30791843

Management of dysphagia in multiple sclerosis: current best practice.

Emanuele D'Amico1, Aurora Zanghì1, Agostino Serra2, Paolo Murabito3, Mario Zappia1, Francesco Patti1, Salvatore Cocuzza2.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) is characterized by extreme variability in both severity and clinical course. It can show severe disabling symptoms, and among them dysphagia is frequently described. However, its management still represents a challenge in the daily care. Areas covered: In this review, we will focus on the clinical recognition and therapeutic strategies to identify and manage dysphagia in people with MS. In the view of a personalized approach, different interventions should be tailored to every single patient. Expert commentary: Multidisciplinary evaluation is mandatory in MS management, and dysphagia represents a perfect model of taking care of a disabling symptom in a chronic disease. Further research is required to better organize a personalized and long-term management of dysphagia phenomenon, through the different subtypes of MS.

Entities:  

Keywords:  DYMUS questionnaire; Dysphagia; multidisciplinary approach; multiple sclerosis; rehabilitation

Mesh:

Year:  2018        PMID: 30791843     DOI: 10.1080/17474124.2019.1544890

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  11 in total

1.  Update on Recent Developments in Communication and Swallowing in Multiple Sclerosis.

Authors:  Francesca De Biagi; Leena Maria Heikkola; Sara Nordio; Leonie Ruhaak
Journal:  Int J MS Care       Date:  2020-12-28

2.  Post-Cerebrovascular Stroke and Early Dysphagia Assessment: A Systematic Review.

Authors:  Antonino Maniaci; Jerome R Lechien; Emanuele D'amico; Ignazio La Mantia; Francesco Cancemi; Francesco Patti; Claudio Faia; Elio Privitera; Milena Di Luca; Giannicola Iannella; Giuseppe Magliulo; Annalisa Pace; Paola Di Mauro; Christian Calvo-Henriquez; Salvatore Ferlito; Gaetano Motta; Giuditta Mannelli; Mario Zappia; Claudio Vicini; Salvatore Cocuzza
Journal:  Acta Biomed       Date:  2022-08-31

Review 3.  Guanidinoacetic Acid as a Nutritional Adjuvant to Multiple Sclerosis Therapy.

Authors:  Sergej M Ostojic
Journal:  Front Hum Neurosci       Date:  2022-05-12       Impact factor: 3.473

4.  Prevalence and Risk Factors of Dysphagia in Patients with Multiple Sclerosis.

Authors:  Mahdi Barzegar; Omid Mirmosayeb; Mina Rezaei; Geir Bjørklund; Nasim Nehzat; Alireza Afshari-Safavi; Vahid Shaygannejad
Journal:  Dysphagia       Date:  2021-02-12       Impact factor: 3.438

5.  Gray and White Matter Correlates of Dysphagia in Progressive Supranuclear Palsy.

Authors:  Heather M Clark; Nirubol Tosakulwong; Stephen D Weigand; Farwa Ali; Hugo Botha; Nha Trang Thu Pham; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Keith A Josephs; Jennifer L Whitwell
Journal:  Mov Disord       Date:  2021-08-23       Impact factor: 10.338

6.  Detection of poststroke oropharyngeal dysphagia with swallowing screening by ultrasonography.

Authors:  Takao Matsuo; Miwa Matsuyama
Journal:  PLoS One       Date:  2021-03-17       Impact factor: 3.240

Review 7.  Vitamin D and Depressive Symptoms in Adults with Multiple Sclerosis: A Scoping Review.

Authors:  Carmen Concerto; Alessandro Rodolico; Alessia Ciancio; Christian Messina; Antimo Natale; Ludovico Mineo; Fortunato Battaglia; Eugenio Aguglia
Journal:  Int J Environ Res Public Health       Date:  2021-12-25       Impact factor: 3.390

Review 8.  Mesenchymal Stem Cell-Derived Extracellular Vesicles and Their Therapeutic Use in Central Nervous System Demyelinating Disorders.

Authors:  Caterina Allegretta; Emanuele D'Amico; Virginia Manuti; Carlo Avolio; Massimo Conese
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

Review 9.  Autoimmune Neurogenic Dysphagia.

Authors:  Panos Stathopoulos; Marinos C Dalakas
Journal:  Dysphagia       Date:  2021-07-05       Impact factor: 2.733

10.  Assessment of factors associated with depression and anxiety among pwMS in Saudi Arabia.

Authors:  Safanah AlSaeed; Nuha M Alkhawajah; Mohsen Ayyash; Salman Aljarallah; Rola Alarieh; Amani Abu-Shaheen
Journal:  BMC Neurol       Date:  2022-03-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.